Voyager Therapeutics Inc [VYGR] stock prices are down -2.91% to $5.0 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The VYGR shares have gain 2.88% over the last week, with a monthly amount glided 14.16%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Citigroup started tracking the stock with Buy rating on December 02, 2024, and set its price target to $12. Leerink Partners started tracking the stock assigning a Outperform rating and suggested a price target of $15 on October 16, 2024. Guggenheim initiated its recommendation with a Buy and recommended $22 as its price target on March 26, 2024. H.C. Wainwright started tracking with a Buy rating for this stock on March 19, 2024, and assigned it a price target of $30. In a note dated March 07, 2024, Citigroup initiated a Buy rating and provided a target price of $16 on this stock.
The stock price of Voyager Therapeutics Inc [VYGR] has been fluctuating between $2.64 and $8.27 over the past year. Currently, Wall Street analysts expect the stock to reach $14.4 within the next 12 months. Voyager Therapeutics Inc [NASDAQ: VYGR] shares were valued at $5.0 at the most recent close of the market. An investor can expect a potential return of 188.0% based on the average VYGR price forecast.
Analyzing the VYGR fundamentals
The Voyager Therapeutics Inc [NASDAQ:VYGR] reported sales of 42.58M for trailing twelve months, representing a drop of -82.42%. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -2.9%, Pretax Profit Margin comes in at -2.52%, and Net Profit Margin reading is -2.53%. To continue investigating profitability, this company’s Return on Assets is posted at -0.34, Equity is -0.38 and Total Capital is -0.44. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Voyager Therapeutics Inc [NASDAQ:VYGR]’s Current Ratio is 5.43. In addition, the Quick Ratio stands at 5.43 and the Cash Ratio stands at 1.05. Considering the valuation of this stock, the price to sales ratio is 6.51, the price to book ratio is 1.14.
Transactions by insiders
Recent insider trading involved Jorgensen Nathan D., Chief Financial Officer, that happened on Oct 03 ’25 when 7666.0 shares were sold. Officer, Fahey Sandell Jacquelyn completed a deal on Oct 03 ’25 to buy 5843.0 shares. Meanwhile, Officer Jorgensen Nathan D. bought 7666.0 shares on Oct 03 ’25.
